Why 20+ Years to Approve a New Alzheimer's Drug?
Alzheimer's & Dementia Weekly,
BREAKTHROUGH
Why has it taken 20 years to approve the new Alzheimer's drug?
6 Minutes,
Two weeks ago a new drug to treat Alzheimer’s disease was given accelerated approval by the US Food and Drug Administration.
A New Alzheimer Drug Is Coming to Market, But Why Did It Take So Long?
The National Interest,
A new drug to treat Alzheimer’s disease was last week given accelerated approval by the United States Food and Drug…
MIL-OSI USA: The FDA’s Big Gamble on a New Alzheimer’s Drug
Foreign Affairs New Zealand,
Source: US State of Connecticut The Food and Drug Administration set off a firestorm of debate when it approved a new drug…
MIL-Evening Report: ‘A slow and painful journey’: why did it take over 20 years to approve the new Alzheimer’s drug?
Foreign Affairs New Zealand,
– By Ralph N. Martins, Professor and Chair in Ageing and Alzheimer’s Disease, Edith Cowan University Shutterstock A new drug to…
Why did it take over 20 years to approve new Alzheimer’s drug?
Mirage News,
A new drug to treat Alzheimer’s disease was last week given accelerated approval by the United States Food and Drug…
'A slow and painful journey': why did it take over 20 years to approve the new Alzheimer's drug?
The Conversation,
A new drug to treat Alzheimer’s disease was last week given accelerated approval by the United States Food and Drug…
FDA approval of controversial Alzheimer's drug could delay discovery of more promising treatments
MedicalXpress,
Alzheimer’s disease is characterized by progressive memory loss, spatial disorientation and many other cognitive and…
FDA approval of controversial Alzheimer's drug could delay discovery of more promising treatments
The Conversation,
The U.S. Food and Drug Administration (FDA) recently approved aducanumab, the first treatment that aims to slow the progression…
大論争の末、2003年以来初のアルツハイマー病治療薬を米食品医薬品局が承認 by Emma Betuel, Dragonfly
Tech Crunch,
2021年6月14日 by Emma Betuel, Dragonfly 前年比100%の成長を遂げたスウェーデンの遠隔医療サービス「Kry」、パンデミックで地位向上 米国時間6月7日月曜日、米食品医薬品局（FDA）は、医薬品メーカーのBiogen（バイオジ…
The FDA's big gamble on the new Alzheimer's drug C. Michael White, University of Connecticut
The Palm Beach Post,
C. Michael White, University of Connecticut The Food and Drug Administration set off a firestorm of debate when it approved a…
The FDA's big gamble on the new Alzheimer's drug
KRQE,
(THE CONVERSATION) The Food and Drug Administration set off a firestorm of debate when it approved a new drug, aducanumab, for…
How the new Alzheimer’s drug works—and why the FDA is under fire for approving it
National Geographic,
Science The first drug approved for the disease in 18 years, Aduhelm shows only scant benefit in clinical trials, and experts…
The FDA's big gamble on the new Alzheimer's drug
Kiowa County Press ,
Do the benefits of approving a drug before confirming it works outweigh the potential costs? monkeybusinessimages/iStock via…
New Alzheimer’s drug aducanumab: what we know so far – and why more research is still needed
Yahoo! News,
For the first time since 2003, the Food and Drug Administration (FDA) has approved a novel treatment for Alzheimer’s disease in…
New Alzheimer’s drug aducanumab: what we know so far – and why more research is still needed
The Conversation,
For the first time since 2003, the Food and Drug Administration (FDA) has approved a novel treatment for Alzheimer’s disease in…
What Explains the FDA’s Big Gamble on Aducanumab, the New Alzheimer’s Drug?
The Wire,
Image: Fakurian Design/Unsplash The Food and Drug Administration set off a firestorm of debate when it approved a new drug…
Viewpoint: The FDA’s big gamble on the new Alzheimer’s drug
Business Journals,
The Food and Drug Administration set off a firestorm of debate when it approved a new drug, aducanumab, for Alzheimer’s disease…
Viewpoint: The FDA’s big gamble on the new Alzheimer’s drug
Business Journals,
The Food and Drug Administration set off a firestorm of debate when it approved a new drug, aducanumab, for Alzheimer’s disease…
The FDA’s big gamble on the new Alzheimer’s drug
The Street,
Courtesy of C. Michael White, University of Connecticut The Food and Drug Administration set off a firestorm of debate when it…
The FDA's Big Gamble on the New Alzheimer's Drug
Hareetz ,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) C.
The FDA's big gamble on the new Alzheimer's drug
Cadillac News,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
MIL-OSI Global: The FDA’s big gamble on the new Alzheimer’s drug
Foreign Affairs New Zealand,
– By C. Michael White, Distinguished Professor and Head of the Department of Pharmacy Practice, University of Connecticut Do…
News story from Big News Network on Thursday 10 June 2021
Big News Network,
The FDA's big gamble on the new Alzheimer's drug
Idaho Press,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) C.
The FDA's big gamble on the new Alzheimer's drug
Fairfield Citizen,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) C.
The FDA's big gamble on the new Alzheimer's drug
San Antonio Express-News,
(THE CONVERSATION) The Food and Drug Administration set off a firestorm of debate when it approved a new drug, aducanumab, for…
The FDA's big gamble on the new Alzheimer's drug
Seattle Post-Intelligencer,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) C.
The FDA's big gamble on the new Alzheimer's drug
New Canaan Advertiser,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) C.
The FDA's big gamble on the new Alzheimer's drug
St. Louis Post-Dispatch,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) C.
The FDA's big gamble on the new Alzheimer's drug
Dispatch-Argus,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) C.
The FDA's big gamble on the new Alzheimer's drug
Lincoln Journal Star,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) C.
The FDA's big gamble on the new Alzheimer's drug
The Conversation,
The Food and Drug Administration set off a firestorm of debate when it approved a new drug, aducanumab, for Alzheimer’s disease…
The FDA's big gamble on the new Alzheimer's drug
Bozeman Daily Chronicle,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) (THE…
The FDA's big gamble on the new Alzheimer's drug
The Darien Times,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) C.
The FDA's big gamble on the new Alzheimer's drug
KULR 8,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) C.
The FDA's big gamble on the new Alzheimer's drug
Shelton Herald,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) C.
The FDA's big gamble on the new Alzheimer's drug
goskagit.com,
(The Conversation is an independent and nonprofit source of news, analysis and commentary from academic experts.) C.
What we know about aducanumab, the new drug to treat Alzheimer's disease
MedicalXpress,
Credit: Unsplash/CC0 Public Domain Earlier this week, the federal Food and Drug Administration (FDA) approved the use of the…
Il nuovo discusso farmaco contro l'Alzheimer - Il Post
Il Post,
L’approvazione negli Stati Uniti dell’Aduhelm (aducanumab), un farmaco che dovrebbe rallentare gli effetti del morbo di…
美國近20年來首次核准阿茲海默症新藥，學者專家怎麼看？
The News Lens ,
議題背景 2020年12月22日，國際期刊「自然」《Nature》照例羅列了每年10大科學關注議題。其中提到「阿茲海默症藥物來到了關鍵時刻」，由美國製藥大廠百健（Biogen）生產的一種藥物「Aducanumab」，經過美國食品藥品監督管理局（FDA）審查的…
FDA最新决定引发争议
sina.com.cn,
SEVIGNYETAL.,NATURE,537,50(2016) 6月7日，美国食品药品管理局（FDA）宣布，批准美国Biogen公司和日本Eisai公司联合研发的抗阿尔茨海默病新药——aducanumab（商品名为Aduhelm）以加速审批渠道上市，这也是…
Почему эксперты были против одобрения нового препарата от болезни Альцгеймера
Medportal,
Автор: 1 минута Адуканумаб относится к классу моноклональных антител. Речь идет о созданных в лаборатории антителах против бета-а…
After contentious debate, FDA approves first Alzheimer's drug since 2003
Yahoo! News,
On Monday, the US Food and Drug Administration granted approval to a keenly-watched Alzheimer’s drug, aducanumab, developed by…
What is the new Alzheimer's drug approved by the US?
Dailyhunt,
The drug aducanumab has been approved by the US. It effectively combats the amyloid beta plaques in the brain that are…
After contentious debate, FDA approves first Alzheimer's drug since 2003
Yahoo! Finance USA,
On Monday, the US Food and Drug Administration granted approval to a keenly-watched Alzheimer’s drug, aducanumab, developed by…
After contentious debate, FDA approves first Alzheimer's drug since 2003
Yahoo! News,
On Monday, the US Food and Drug Administration granted approval to a keenly-watched Alzheimer’s drug, aducanumab, developed by…
After contentious debate, FDA approves first Alzheimer's drug since 2003
Yahoo!,
On Monday, the US Food and Drug Administration granted approval to a keenly-watched Alzheimer’s drug, aducanumab, developed by…
After contentious debate, FDA approves first Alzheimer's drug since 2003
Yahoo! News,
On Monday, the US Food and Drug Administration granted approval to a keenly-watched Alzheimer’s drug, aducanumab, developed by…
After contentious debate, FDA approves first Alzheimer's drug since 2003
Yahoo! Finance USA,
On Monday, the US Food and Drug Administration granted approval to a keenly-watched Alzheimer’s drug, aducanumab, developed by…
After contentious debate, FDA approves first Alzheimer’s drug since 2003
Tech Crunch,
On Monday, the US Food and Drug Administration granted approval to a keenly-watched Alzheimer’s drug, aducanumab, developed by…
After contentious debate, FDA approves first Alzheimer's drug since 2003
Daily Magazine,
On Monday, the US Food and Drug Administration granted approval to a keenly-watched Alzheimer's drug, aducanumab, developed by…
FDA approves new Alzheimer’s drug which claims to slow disease
WSB-TV Atlanta,
Update: 11:21 a.m. ET June 7, 2021 : From the Associated Press -- The FDA has approved the first new drug for Alzheimer’s…
Alzheimer-Medikament aus Zürich – Wie alles begann
Berner Zeitung,
Vor über 20 Jahren starteten zwei Hirnforscher und ihre Teams an der Universität Zürich mit der Suche nach Antikörpern gegen…
Alzheimer-Medikament aus Zürich – Wie alles begann
Basler Zeitung,
Vor über 20 Jahren starteten zwei Hirnforscher und ihre Teams an der Universität Zürich mit der Suche nach Antikörpern gegen…
Alzheimer-Medikament aus Zürich: Wie alles begann
Der Bund,
Vor über 20 Jahren starteten zwei Hirnforscher und ihre Teams an der Universität Zürich mit der Suche nach Antikörpern gegen…
Alzheimer-Medikament aus ZürichWie alles begann
Tages Anzeiger,
Alzheimer-Medikament – Wie alles begann Vor über 20 Jahren starteten zwei Hirnforscher und ihre Teams an der Universität Zürich…
FDA set to rule Monday on Alzheimer’s drug
FOX13 Memphis,
Update: 11:21 a.m. ET June 7, 2021 : From the Associated Press -- The FDA has approved the first new drug for Alzheimer’s…
FDA set to rule Monday on Alzheimer’s drug
WFTV 9,
On Monday, the U.S. Food and Drug Administration is expected to announce whether a new drug to treat Alzheimer’s disease will…
FDA set to rule Monday on Alzheimer’s drug
WPXI,
On Monday, the U.S. Food and Drug Administration is expected to announce whether a new drug to treat Alzheimer’s disease will…
FDA set to rule Monday on Alzheimer’s drug
Action News Jax,
On Monday, the U.S. Food and Drug Administration is expected to announce whether a new drug to treat Alzheimer’s disease will…
FDA set to rule Monday on Alzheimer’s drug
Kiro 7,
On Monday, the U.S. Food and Drug Administration is expected to announce whether a new drug to treat Alzheimer’s disease will…
FDA set to rule Monday on Alzheimer’s drug
WHIOTV7,
On Monday, the U.S. Food and Drug Administration is expected to announce whether a new drug to treat Alzheimer’s disease will…
FDA set to rule Monday on Alzheimer’s drug
Fox 23 Tulsa,
On Monday, the U.S. Food and Drug Administration is expected to announce whether a new drug to treat Alzheimer’s disease will…
The First Treatment for Alzheimer’s Disease Could Get Its Long-Awaited FDA Approval Today. Or Not
DNYUZ,
While Alzheimer’s disease was first described by Alois Alzheimer in 1906, more than 200 years later, doctors still have no…
The First Treatment for Alzheimer’s Disease Could Get Its Long-Awaited FDA Approval Today. Or Not
Yahoo! News,
Peter Wooding, with his his wife JoAnn, receiving an infusion of the experimental Alzheimer's drug aducanumab in 2017.
The First Treatment for Alzheimer’s Disease Could Get Its Long-Awaited FDA Approval Today. Or Not
TIME Magazine,
W hile Alzheimer’s disease was first described by Alois Alzheimer in 1906, more than 200 years later, doctors still have no…
The First Treatment for Alzheimer’s Disease Is Here
PressNewsAgency,
Alzheimers disease was first described by Alois Alzheimer in 1906, and now, more than 100 years later, doctors have an…
FDA Poised For Decision On Controversial Alzheimer's Drug
KPCC : Southern California Public Radio,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
Omaha Public Radio,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
WCBE ,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
North East Public Radio,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
KPBS,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
KUNM,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
WVPE,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
Northeastern Indiana Public Radio ,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
WVTF,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
WKAR,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
WVXU,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
New Hampshire Public Radio,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
Northern Public Radio,
Dr. William Burke reviewed a PET brain scan at Banner Alzheimer's Institute in Phoenix in 2018.
FDA Poised For Decision On Controversial Alzheimer's Drug
KTEP El Paso,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
SDPB Radio,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
Tri States Public Radio,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
Radio Acadie,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
Public Radio East,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
WJCT,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
Central Coast Public Radio,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
Delmarva Public Radio,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
Kansas Public Radio,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
Arizona Public Radio,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
WXPR,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
WUKY,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
Georgia Public Radio,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
A Koahnic Broadcast Station,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
Witchita's Public Radio,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
FDA Poised For Decision On Controversial Alzheimer's Drug
KRWG TV/FM,
A drug called aducanumab could become the first approved treatment designed to alter the course of Alzheimer's disease, rather…
Aducanumab: Is an Alzheimer's drug coming soon?
Yourstory,
Great hopes in Alzheimer's research are currently pinned on the drug aducanumab.
Aducanumab: Is an Alzheimer's drug coming soon?
MSN,
Great hopes in Alzheimer's research are currently pinned on the drug aducanumab.
Aducanumab: Is an Alzheimer’s drug coming soon?
DNYUZ,
Great hopes in Alzheimer’s research are currently pinned on the drug aducanumab.